HCM
SNY icon

Highbridge Capital Management’s Sanofi SNY Stock Holding History

Highbridge Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,000
Closed -$747K – 1934
2017
Q3 		$747K Buy
+15,000
New +$726K 0.01% 721

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Highbridge Capital Management's SNY Position: Q4 2017 in Review

Highbridge Capital Management sold out of Sanofi (SNY) in Q4 2017, closing a stake of 15,000 shares — an estimated $747K sold.

Highbridge Capital Management first reported a position in SNY in Q3 2017 and held it in 1 quarter. The position peaked at $747K in Q3 2017. 504 funds tracked by Wall St. Rank hold SNY as of Q4 2017.

  • Highbridge Capital Management reported no remaining Sanofi position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 15,000 Sanofi shares in Q4 2017, an estimated $747K.
  • Highbridge Capital Management first reported a position in Sanofi in Q3 2017 and held it in 1 quarter.
  • Highbridge Capital Management's Sanofi position peaked at $747K in Q3 2017.
  • 504 funds tracked by Wall St. Rank held Sanofi as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.